Skip to main content

Aurinia Pharmaceuticals – Healthy correction to buy

Aurinia Pharmaceuticals – Healthy correction to buy

Aurinia Pharmaceutical ( NASDAQ: $AUPH ) is an absolutely perfect Weinstein play: breakout of resistance line with an explosion of trading volumes, a rising 30-week average, strongly positive relative strength. The stock price follows perfectly the script and offers a new buying opportunity by hitting back the previous resistance line now turned into support line […]

EURTRY – Something must yield!

EURTRY – Something must yield!

In a previous post I mentioned the extremely overbought condition of the $USDTRY pair. The situation is not any different regarding the $EURTRY pair. Therefore it appears that the turkish Lira should be close to ending its multi-year decline since August 2012 (bottom left of the chart) and is on the verge or recovering some […]

BYD – An electric trap

BYD – An electric trap

The case for BYD (OTC PINK: $BYDDY) – the leading Chinese electric vehicles and renewable energy company – is very clear. The share price is entrapped in a long term contracting triangle and it has been painfully climbing a wall of worries since it bottomed in mid-2011. The 30-week moving average is trending upwards but […]

Editas Medicine – Accumulation phase

Editas Medicine – Accumulation phase

Editas Medicine ( Nasdaq: $EDIT ) is a gene editing company at the leading edge of the revolutionary CRISPR technology. The rising exchange volumes on the weekly scale has the hallmarks of rising interest and shares accumulation, whereas the relative strength is also progressively rising and should soon turn positive. Last week the price broke […]

Turkish Lira – massively oversold against the US Dollar

Turkish Lira – massively oversold against the US Dollar

The $USDTRY pair appears to be extremely overbought on longer time frames, which in other terms means that the Turkish Lira is massively oversold against the Greenback. On the six-month time frame this overbought condition is accompanied by a shooting star candle, which is a strong indication that the uptrend should stall (for the least) […]

MAZOR Robotics (MZOR), a perfect long term biotech play

MAZOR Robotics (MZOR), a perfect long term biotech play

#Mazor Robotics (MZOR) appears to be a perfect Weinstein winner. The price broke out of its long term trading range in March 2017 with a strong volume increase and with a positive relative strength compared to the NASDAQ Composite Index. The current consolidation phase should soon give way to higher prices. Disclosure: I am long […]